نمایش مختصر رکورد

dc.contributor.authorEmamghoreishi, Masoumehen_US
dc.contributor.authorFarrokhi, Majiden_US
dc.contributor.authorAmiri, Atenaen_US
dc.contributor.authorKeshavarz, Mojtabaen_US
dc.date.accessioned1399-07-09T12:38:43Zfa_IR
dc.date.accessioned2020-09-30T12:38:43Z
dc.date.available1399-07-09T12:38:43Zfa_IR
dc.date.available2020-09-30T12:38:43Z
dc.date.issued2019-04-01en_US
dc.date.issued1398-01-12fa_IR
dc.date.submitted2018-07-02en_US
dc.date.submitted1397-04-11fa_IR
dc.identifier.citationEmamghoreishi, Masoumeh, Farrokhi, Majid, Amiri, Atena, Keshavarz, Mojtaba. (2019). The neuroprotective mechanism of cinnamaldehyde against amyloid-β in neuronal SHSY5Y cell line: The role of N-methyl-D-aspartate, ryanodine, and adenosine receptors and glycogen synthase kinase-3β. Avicenna Journal of Phytomedicine, 9(3), 271-280. doi: 10.22038/ajp.2019.12385en_US
dc.identifier.issn2228-7930
dc.identifier.issn2228-7949
dc.identifier.urihttps://dx.doi.org/10.22038/ajp.2019.12385
dc.identifier.urihttp://ajp.mums.ac.ir/article_12385.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/425601
dc.description.abstract<span style="font-size: medium;"><strong>Objective:</strong> Cinnamaldehyde may be responsible for some health benefits of cinnamon such as its neuroprotective effects. We aimed to investigate the cinnamaldehyde neuroprotective effects against amyloid beta (Aβ) in neuronal SHSY5Y cells and evaluate the contribution of N-methyl-D-aspartate (NMDA), ryanodine, and adenosine receptors and glycogen synthase kinase (GSK)-3β, to its neuroprotective effects. </span><br /> <span style="font-size: medium;"><strong>Materials and Methods:</strong> After seeding the cells in 96-well plates, adenosine (20, 40, 80, and 120 µM), NMDA (20, 40, 80, and 120 µM), and dantrolene (as a ryanodine receptor antagonist; 2, 4, 6, 8, and 16 µM) were added to the medium containing Aβ25-35 and/or cinnamaldehyde. The 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide method was used to assess neurotoxicity and western blot to measure the GSK-3β protein level. </span><br /> <span style="font-size: medium;"><strong>Results:</strong> Cinnamaldehyde (15, 20, 23, and 25 μM) significantly reversed Aβ-induced toxicity in SHSY5Y neuronal cells. Adenosine (20, 40, 80 and 120 μM) inhibited the neuroprotective effects of cinnamaldehyde (15 μM). NMDA (20, 40, 80, and 120 μM) reduced cinnamaldehyde (15 and 23 μM) neuroprotective effects against Aβ neurotoxicity. Dantrolene (2, 4, 8, and 16 μM) significantly reduced cinnamaldehyde (15 μM) neuroprotective effects. Cinnamaldehyde (15 and 23 μM) suppressed the Aβ-induced increment of GSK-3β protein level.  </span><br /> <strong>Conclusion:</strong> NMDA and adenosine receptors suppression together with ryanodine receptors stimulation may be relevant to cinnamaldehyde neuroprotective effects against Aβ neurotoxicity. Moreover, the inhibition of GSK-3β may contribute to the cinnamaldehyde neuroprotection.en_US
dc.format.extent764
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoen_US
dc.publisherMashhad University of Medical Sciencesen_US
dc.relation.ispartofAvicenna Journal of Phytomedicineen_US
dc.relation.isversionofhttps://dx.doi.org/10.22038/ajp.2019.12385
dc.subjectAdenosineen_US
dc.subjectCinnamaldehydeen_US
dc.subjectDantroleneen_US
dc.subjectGlycogen Synthase Kinaseen_US
dc.subjectNeuroprotectionen_US
dc.subjectN-methyl-D-aspartateen_US
dc.subjectPharmacologyen_US
dc.titleThe neuroprotective mechanism of cinnamaldehyde against amyloid-β in neuronal SHSY5Y cell line: The role of N-methyl-D-aspartate, ryanodine, and adenosine receptors and glycogen synthase kinase-3βen_US
dc.typeTexten_US
dc.typeOriginal Research Articleen_US
dc.contributor.departmentDepartment of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iranen_US
dc.contributor.departmentShiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iranen_US
dc.contributor.departmentShiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iranen_US
dc.contributor.departmentShiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.en_US
dc.citation.volume9
dc.citation.issue3
dc.citation.spage271
dc.citation.epage280
nlai.contributor.orcid0000-0003-2863-1309


فایل‌های این مورد

Thumbnail

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد